Insider Transactions in Q4 2025 at Kairos Pharma, Ltd. (KAPA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 08
2025
|
Neil Bhowmick Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
171,756
+11.58%
|
-
|
|
Oct 08
2025
|
Hyun W. Bae Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,084
+20.64%
|
-
|
|
Oct 08
2025
|
Ramachandran Murali VP of Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
152,672
+33.76%
|
-
|
|
Oct 08
2025
|
Rahul Singhvi Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,084
+27.95%
|
-
|
|
Oct 08
2025
|
Hansoo Michael Keyoung Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,084
+39.62%
|
-
|
|
Oct 08
2025
|
John S Yu CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
190,840
+45.34%
|
-
|
|
Oct 08
2025
|
Doug Samuelson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
152,672
+34.25%
|
-
|